原著論文1
Ohkawara B, Cabrera-Serrano M, Nakata T, et al.
LRP4 third beta-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner
Hum Mol Genet
, 23
(7)
, 1856-1868
(2014)
10.1093/hmg/ddt578
原著論文2
Kawakami Y, Ito M, (他7名), Ohno K.
Anti-MuSK autoantibodies block binding of collagen Q to MuSK
Neurology
, 77
(20)
, 1819-1826
(2011)
10.1212/WNL.0b013e318237f660
原著論文3
Kokunai Y, Nakata T, Furuta M, et al.
A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1
Neurology
, 82
(12)
, 1058-1064
(2014)
10.1212/WNL.0000000000000239
原著論文4
Ito M, Suzuki Y, Okada T, Fukudome T, Yoshimura T, Masuda A, Takeda S, Krejci E, Ohno K.
Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction
Mol Ther
, 20
(7)
, 1384-1392
(2012)
10.1038/mt.2012.34
原著論文5
Nasrin F, Rahman MA, Masuda A, Ohe K, Takeda J, Ohno K.
HnRNP C, YB-1 and hnRNP L coordinately enhance skipping of human MUSK exon 10 to generate a Wnt-insensitive MuSK isoform
Sci Rep
, 4
(-)
, 6841-6841
(2014)
10.1038/srep06841
原著論文6
Ito M*, Ehara Y*, Li J, Inada K, Ohno K.
Protein-anchoring therapy of biglycan for mdx mouse model of Duchenne muscular dystrophy
Hum Gene Ther
, 28
(5)
, 428-436
(2017)
10.1089/hum.2015.088
原著論文7
Nakata T, Ito M, (他9名), Ohno K.
Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction
Hum Mutat
, 34
(7)
, 997-1004
(2013)
10.1002/humu.22325
原著論文8
Ohno K, Rahman MA, Nazim M, Nasrin F, Lin Y, Takeda JI, Masuda A.
Splicing regulation and dysregulation of cholinergic genes expressed at the neuromuscular junction
J Neurochem
, 142
(2)
, 64-72
(2017)
10.1111/jnc.13954
原著論文9
Selcen D, Shen XM, Milone M, Brengman J, Ohno K, Deymeer F, Finkel R, Rowin J, Engel AG
Gfpt1-myasthenia: Clinical, structural, and electrophysiologic heterogeneity
Neurology
, 156
(81)
, 370-378
(2013)
10.1212/WNL.0b013e31829c5e9c
原著論文10
Rahman MA, Masuda A, Ohe K, Ito M, Hutchinson DO, Mayeda A, Engel AG, Ohno K.
HnRNP L and hnRNP LL antagonistically modulate PTB-mediated splicing suppression of CHRNA1 pre-mRNA
Sci Rep
, 3
(-)
, 2931-2931
(2013)
10.1038/srep02931
原著論文11
Shen X-M*, Okuno T*, Milone M, Otsuka K, Takahashi K, Komaki H, Giles E, Ohno K, Engel AG.
Mutations causing slow-channel myasthenia reveal that a valine ring in the channel pore of muscle AChR is optimized for stabilizing channel gating
Hum Mutat
, 37
(10)
, 1051-1059
(2016)
10.1002/humu.23043
原著論文12
Masuda A, Takeda J, Okuno T, et al.
Position-specific binding of FUS to nascent RNA regulates mRNA length
Genes Dev
, 29
(10)
, 1045-1057
(2015)
10.1101/gad.255737.114
原著論文13
Selcen D, Ohkawara B, Shen XM, et al.
Impaired Synaptic Development, Maintenance, and Neuromuscular Transmission in LRP4-Related Myasthenia
JAMA Neurol
, 72
(8)
, 889-896
(2015)
10.1001/jamaneurol.2015.0853
原著論文14
Nazim M, Masuda A, Rahman MA, Nasrin F, Takeda JI, Ohe K, Ohkawara B, Ito M, Ohno K.
Competitive regulation of alternative splicing and alternative polyadenylation by hnRNP H and CstF64 determines acetylcholinesterase isoforms
Nucleic Acids Res
, 45
(3)
, 1455-1468
(2017)
10.1093/nar/gkw823
原著論文15
Rahman MA, Azuma Y, Nasrin F, et al.
SRSF1 and hnRNP H antagonistically regulate splicing of COLQ exon 16 in a congenital myasthenic syndrome
Sci Rep
, 5
(-)
, 13208-13208
(2015)
10.1038/srep13208
原著論文16
Otsuka K, Ito M, Ohkawara B, et al.
Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling
Sci Rep
, 5
(-)
, 13928-13928
(2015)
10.1038/srep13928
原著論文17
Chen G, Masuda A, Konishi H, et al.
Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy
Sci Rep
, 6
(-)
, 25317-25317
(2016)
10.1038/srep25317
原著論文18
Nakashima H*, Ohkawara B*, (他11名), Ishiguro N, Ohno K.
R-spondin 2 promotes acetylcholine receptor clustering at the neuromuscular junction via Lgr5
Sci Rep
, 6
(-)
, 28512-28512
(2016)
10.1038/srep28512
原著論文19
Ohno K, Ohkawara B, Ito M.
Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders
Expert Opin Ther Targets
, 21
(10)
, 949-958
(2017)
10.1080/14728222.2017.1369960
原著論文20
Ito M, Ohno K.
Protein-anchoring therapy to target extracellular matrix proteins to their physiological destinations
Matrix Biol
, 68-69
(-)
, 628-636
(2018)
10.1016/j.matbio.2018.02.014.